arrow
K

Kimberly F. Fennell

pfizer discovery sciences
H指数:15
被引数:1,010

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines

BNT162b2 JN.1和KP.2适应型COVID-19疫苗的免疫学和生物物理学特征

2025-12-050
OAAI
Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca2+ dependent allosteric binding site

通过靶向一个Ca2+依赖性的别构结合位点抑制肽基精氨酸脱亚胺酶(PAD1-4)

2025-05-160
OA
An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism
2023-09-238
OAAI
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
2022-12-2311
PRE
Structural basis of the acyl-transfer mechanism of human GPAT1
2022-12-153
PRE
Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yObenzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor Related Orphan Receptor C2 Inverse Agonist
2018-08-2123
OAAI
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor (vol 60, pg 5673, 2017)
2018-04-060
PREAI
Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase
2017-12-0558
PREAI
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
2017-06-1626
PREAI
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism
2016-07-1917
OAAI
Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of Schizophrenia
2011-06-0854
PREAI